NetApp Advance Offers Organizations Next Level Hybrid Cloud Flexibility and Efficiency

7.2.2023 16:00:00 EET | Business Wire | Press release

NetApp® (NASDAQ: NTAP), a global, cloud-led, data-centric software company, today announced the availability of NetApp Advance, a new portfolio of storage programs and guarantees to help customers cost-effectively future proof on-premises environments.

NetApp Advance evolves the storage lifecycle, allowing organizations the possibility to avoid complex, costly, and time-consuming refresh cycles by enabling ongoing, non-disruptive hardware upgrades – and ensures efficient, secure and sustainable storage with new guarantees offered to meet the needs of organizations today.

With simplified storage ownership and management, NetApp Advance can help to eliminate complex, time-consuming, and costly upgrade cycles while staying current with technology innovations. Organizations can choose on-premises or cloud storage options to future-proof environments to scale securely, seamlessly, and non-disruptively as they grow. Advance also brings sustainability and efficiency best practices and capabilities that continually improve energy efficiency and operational performance to reduce carbon footprint.

“NetApp Advance brings peace of mind to forward looking organizations in need of storage solutions that can adapt and scale as their business changes and grows,” said Sandeep Singh, Senior Vice President, Enterprise Storage at NetApp. “With NetApp Advance, we’re offering customers the confidence that their storage investment today will provide the flexibility to meet their hybrid cloud needs for the future.”

New benefits of NetApp Advance include:

Reducing the cost, complexity, and disruption of tech refreshes by buying once and evolving continuously.
Greatly reducing the risk previously associated with the journey to hybrid cloud with the flexibility to easily scale out to the cloud if or when business demands it.

Part of NetApp Advance, the new NetApp Storage Lifecycle Program offers:

No additional cost non-disruptive upgrades to the latest storage controller technology every three, four, or five years
Option to upgrade controllers at only incremental cost prior to three-year renewal.
Optional capacity refresh allowing customers to replace lower capacity drives as part of a storage refresh, so customers never have to buy the same capacity twice and can achieve a more efficient & sustainable data center footprint.
Remotely managed software updates including non-disruptive ONTAP software upgrades packed with new capabilities and enhancements.
Premier-level support services, with Active IQ and Cloud Insights that enable full-stack visibility and AIOps to streamline observability of the infrastructure beyond the storage layer in a single interface to quickly pinpoint issues and simplify troubleshooting. While ONTAP Essentials provides detailed overviews of ONTAP inventories, workloads, and data protection.

Additionally, the NetApp Storage Lifecycle Program introduces the NetApp Cloud Advantage Program, which allows organizations to trade in controllers for full credit toward their choice of NetApp cloud solutions to enable easy scale out to the cloud in order to meet changing business demands – and two new guarantees to benefit organizations in need of agile and efficient storage consumption options and models.

NetApp’s 4:1 SAN Storage Efficiency Guarantee offers that if workload efficiency goals are not met, NetApp will rectify this at no cost to the customer. Available for all AFF all-flash systems.*

NetApp will also introduce a new Sustainability SLA for NetApp Keystone customers. Keystone comes standard with 99.999 percent data availability.* Now Keystone will provide a standard Watts/TB for each SLA-based performance level, with service credits available if those targets are not met. This new SLA is planned for availability in the first calendar quarter of 2023 and specific terms and conditions will apply.

With NetApp BlueXP, customers will soon have access to a new, industry-first Sustainability Dashboard – available for preview in the first quarter of NetApp’s fiscal year 2024. This dashboard provides a holistic view of an organization’s IT environment with real data measuring power, energy and heat usage to deliver a sustainability scorecard. By offering actionable insights with AIOps to improve their overall score and reduce their storage carbon footprint, organizations can simply and easily monitor and achieve their IT sustainability goals.

“As a NetApp partner, EVT is helping our joint customers optimize their IT environment and accelerate their journey to the cloud,” said Scott Gelb, Solutions Architect at Enterprise Vision Technologies. “With NetApp’s announcement of NetApp Advance, we’re now perfectly positioned to help customers do just that by providing a flexible path to non-disruptive upgrades of their on-premises hardware systems, or to right-size their hybrid cloud environments as they scale out to any cloud with credits toward their choice of NetApp cloud solutions. By future-proofing their investment with Advance, we can limit risk and offer infrastructure agility as their business evolves.”

NetApp Advance is available today. Also announced today, the upcoming availability of NetApp AFF C-Series, a new family of capacity flash storage options that deliver lower cost all-flash storage, and NetApp AFF A150, a new entry-level storage system in the AFF A-Series family of all-flash systems.

*Terms and conditions will apply.

Additional Resources

About NetApp

NetApp is a global, cloud-led, data-centric software company that empowers organizations to lead with data in the age of accelerated digital transformation. The company provides systems, software and cloud services that enable them to run their applications optimally from data center to cloud, whether they are developing in the cloud, moving to the cloud, or creating their own cloudlike experiences on premises. With solutions that perform across diverse environments, NetApp helps organizations build their own data fabric and securely deliver the right data, services, and applications to the right people—anytime, anywhere. Learn more at www.netapp.com or follow us on Twitter, LinkedIn, Facebook, and Instagram.

NETAPP, the NETAPP logo, and the marks listed at www.netapp.com/TM are trademarks of NetApp, Inc. Other company and product names may be trademarks of their respective owners.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230207005469/en/

Contact information

Media Contact:
Kenya Hayes
NetApp
kenya.hayes@netapp.com

Investor Contact:
Lance Berger
NetApp
lance.berger@netapp.com

About Business Wire

Business Wire

http://www.businesswire.com

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 20:52:00 EEST | Press release

International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he has served as pro bono counsel to five Nobel Peace Prize laureates. The New York Times has referred to him as "The Extractor" for his work freeing political prisoners worldwide. Genser's decision to support Yim Leak's team comes as the businessman faces an asset freeze exceeding 20 billion baht (more than U

Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 18:38:00 EEST | Press release

Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co

Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli ® (Relacorilant)18.9.2026 15:00:00 EEST | Press release

Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth

Enhertu ® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 15:00:00 EEST | Press release

Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at the 2025 European Society for Medical Oncology (#ESMO25) Congress and subsequently published in The New England Journal of Medicine. The recommendation will now be reviewed by the European Commission, which has the authority to grant marketing authorizations for medicines in the EU. In DES

CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca ® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 13:58:00 EEST | Press release

Alfasigma S.p.A, a global pharmaceutical company with a focus on innovation in rare disease and specialty care in areas where there is significant unmet patient need, today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for Jyseleca® (filgotinib), an oral, once-daily JAK1 preferential inhibitor, for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy. Following this positive opinion, the application is now referred to the European Commission (EC) for final action. The EC’s decision is expected in the next weeks. “At present, half of people living with axSpA fail to adequately respond to treatment, leaving them with years of preventable struggle with persistent pain and other impactful symptoms,” said Daniele D'Ambrosio, Chief Development Officer, Alfasigma. “This

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom